Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111723335 | 11172333 | 5 | F | 2015 | 20160926 | 20150608 | 20160930 | PER | US-PFIZER INC-2015187434 | PFIZER | 61.00 | YR | F | Y | 88.45000 | KG | 20160930 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111723335 | 11172333 | 1 | PS | LYRICA | PREGABALIN | 1 | 150 MG AT NIGHT AND 50 MG CAPSULE IN THE MORNING | D | L25318 | 21446 | CAPSULE, HARD | BID | |||||||
| 111723335 | 11172333 | 2 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK, AS NEEDED (HYDROCODONE BITARTRATE: 10 MG, PARACETAMOL: 325 MG) | 0 | |||||||||||
| 111723335 | 11172333 | 3 | C | IBUPROFEN. | IBUPROFEN | 1 | 800 MG, AS NEEDED | 0 | 800 | MG | |||||||||
| 111723335 | 11172333 | 4 | C | TRAMADOL. | TRAMADOL | 1 | 50 MG, AS NEEDED | 0 | 50 | MG | |||||||||
| 111723335 | 11172333 | 5 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG, 1X/DAY | 0 | 25 | MG | QD | ||||||||
| 111723335 | 11172333 | 6 | C | LOSARTAN. | LOSARTAN | 1 | UNK UNK, 1X/DAY | 0 | QD | ||||||||||
| 111723335 | 11172333 | 7 | C | METOPROLOL. | METOPROLOL | 1 | 50 MG, 1X/DAY | 0 | 50 | MG | QD | ||||||||
| 111723335 | 11172333 | 8 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, DAILY | 0 | 81 | MG | |||||||||
| 111723335 | 11172333 | 9 | C | ACIPHEX | RABEPRAZOLE SODIUM | 1 | 1 DF, 2X/DAY | 0 | 1 | DF | BID | ||||||||
| 111723335 | 11172333 | 10 | C | CALCIUM | CALCIUM | 1 | 500 MG, DAILY | 0 | 500 | MG | |||||||||
| 111723335 | 11172333 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 1000 UNKNOWN DOSING, WAS TAKING TEN DAILY | 0 | 10 | DF | |||||||||
| 111723335 | 11172333 | 12 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK, 1X/DAY (5000 UNKNOWN DOSING) | 0 | QD | ||||||||||
| 111723335 | 11172333 | 13 | C | XANAX | ALPRAZOLAM | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 111723335 | 11172333 | 14 | C | ALEVE | NAPROXEN SODIUM | 1 | 2 DF, 2X/DAY | 0 | 2 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111723335 | 11172333 | 1 | Fibromyalgia |
| 111723335 | 11172333 | 2 | Pain |
| 111723335 | 11172333 | 3 | Pain |
| 111723335 | 11172333 | 4 | Pain |
| 111723335 | 11172333 | 5 | Blood pressure abnormal |
| 111723335 | 11172333 | 6 | Blood pressure abnormal |
| 111723335 | 11172333 | 7 | Blood pressure abnormal |
| 111723335 | 11172333 | 9 | Gastrooesophageal reflux disease |
| 111723335 | 11172333 | 10 | Osteoporosis |
| 111723335 | 11172333 | 11 | Vitamin D increased |
| 111723335 | 11172333 | 13 | Anxiety |
| 111723335 | 11172333 | 14 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111723335 | 11172333 | Anxiety | |
| 111723335 | 11172333 | Drug ineffective | |
| 111723335 | 11172333 | Headache | |
| 111723335 | 11172333 | Intentional product misuse | |
| 111723335 | 11172333 | Malaise | |
| 111723335 | 11172333 | Nausea | |
| 111723335 | 11172333 | Pain | |
| 111723335 | 11172333 | Regurgitation | |
| 111723335 | 11172333 | Spinal pain | |
| 111723335 | 11172333 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111723335 | 11172333 | 11 | 20160302 | 0 | ||
| 111723335 | 11172333 | 12 | 20160303 | 0 |